Alphabet-A
GOOGL
Alphabet-C
GOOG
MicroStrategy
MSTR
Tesla
TSLA
Ecopetrol
EC
US Stock MarketDetailed Quotes
ATRC AtriCure
- 33.980
- +0.040+0.12%
Close Dec 10 16:00 ET
- 33.980
- 0.0000.00%
Post 16:02 ET
1.66BMarket Cap-40939P/E (TTM)
34.400High33.490Low386.43KVolume34.200Open33.940Pre Close13.13MTurnover0.82%Turnover RatioLossP/E (Static)48.75MShares39.04552wk High3.56P/B1.60BFloat Cap18.94052wk Low--Dividend TTM47.09MShs Float89.180Historical High--Div YieldTTM2.68%Amplitude1.000Historical Low33.973Avg Price1Lot Size
About AtriCure Company
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Company Profile
SymbolATRC
Company NameAtriCure
Listing DateAug 5, 2005
Issue Price12.00
Founded1994
MarketNASDAQ
Employees1200
Fiscal Year Ends12-31
Address7555 Innovation Way
CityMason
ProvinceOhio
CountryUnited States of America
Zip Code45040
Phone1-513-755-4100
Websitehttp://www.atricure.com
Company Executives
- Name
- Position
- Salary
- Michael H. Carrel
- Director, President and Chief Executive Officer
- 8.75M
- Dr. Vinayak Doraiswamy, PhD
- Chief Scientific Officer
- --
- Salvatore Privitera
- Chief Technical Officer
- 2.13M
- Deborah Lee Yount
- Chief Human Resources Officer
- --
- Angela L. Wirick
- Chief Financial Officer and Principal Accounting Officer
- 2.92M
- Douglas J. Seith
- Chief Operating Officer
- 3.50M
- Justin J. Noznesky
- Chief Marketing and Strategy Officer
- --
- Karl S. Dahlquist
- Chief Legal Officer
- 2.13M
- B. Kristine Johnson
- Chairman of the Board
- 264.97K
- Regina E. Groves
- Independent Director
- 232.47K
- Sven A. Wehrwein
- Independent Director
- 227.47K
- Karen N. Prange
- Independent Director
- 219.97K
- Shlomo Nachman
- Independent Director
- --
- Maggie Yuen
- Independent Director
- 209.97K
- Robert S. White
- Independent Director
- 225.47K
- Deborah H. Telman
- Independent Director
- 212.47K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.